Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Namrata P Patel Insider Profile
4 Followers
Namrata P Patel, Director at Oxford BioMedica, holds 9.17K shares in Oxford BioMedica (Ticker: OXBDF). Most recently, Namrata P Patel Bought $1,670 shares of Oxford BioMedica on Oct 11, 2023 for an estimated value of 4.99K.
Namrata P Patel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Namrata P Patel's holdings
Insider Roles
Director
Roles that Namrata P Patel holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Namrata P Patel
Namrata P Patel's Trading History
List of latest transactions for each holding click on a transaction to see Namrata P Patel's performance on stock
You May Also Like
Namrata P Patel insider profile FAQ
What is the percentage of profitable transactions made by Namrata P Patel?
The percentage of profitable transactions made by Namrata P Patel is ―.
What is the average return per transaction made by Namrata P Patel?
The average return per transaction made by Namrata P Patel is ―.
What stocks does Namrata P Patel hold?
Namrata P Patel holds: OXBDF stocks.
What was Namrata P Patel’s latest transaction?
Namrata P Patel latest transaction was an Informative Buy of $4.99K.
What was Namrata P Patel's most profitable transaction?
Namrata P Patel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Namrata P Patel's role in Oxford BioMedica?
Namrata P Patel's role in Oxford BioMedica is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.